Osiris Therapeutics (Osiris Therapeutics) Total Liabilities : $23.0 Mil (As of Dec. 2018)

View and export this data going back to 2006. Start your Free Trial

What is Osiris Therapeutics Total Liabilities?

Osiris Therapeutics's Total Liabilities for the quarter that ended in Dec. 2018 was $23.0 Mil.

Osiris Therapeutics's quarterly Total Liabilities increased from Jun. 2018 ($38.15 Mil) to Sep. 2018 ($38.84 Mil) but then declined from Sep. 2018 ($38.84 Mil) to Dec. 2018 ($22.97 Mil).

Osiris Therapeutics's annual Total Liabilities declined from Dec. 2016 ($39.32 Mil) to Dec. 2017 ($36.73 Mil) and declined from Dec. 2017 ($36.73 Mil) to Dec. 2018 ($22.97 Mil).

Osiris Therapeutics Total Liabilities Historical Data

The historical data trend for Osiris Therapeutics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Osiris Therapeutics Total Liabilities Chart

Osiris Therapeutics Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Total Liabilities

Get a 7-Day Free Trial

12.77

37.12

39.32

36.73

22.97

Osiris Therapeutics Quarterly Data
	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18
Total Liabilities	Get a 7-Day Free Trial															36.73	39.64	38.15	38.84	22.97

Osiris Therapeutics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Osiris Therapeutics's Total Liabilities for the fiscal year that ended in Dec. 2018 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	20.592	+	(0	+	2.382
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	23.0

Total Liabilities	=	Total Assets (A: Dec. 2018 )	-	Total Equity (A: Dec. 2018 )
	=	101.502	-	78.528
	=	23.0

Osiris Therapeutics's Total Liabilities for the quarter that ended in Dec. 2018 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	20.592	+	(0	+	2.382
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	23.0

Total Liabilities	=	Total Assets (Q: Dec. 2018 )	-	Total Equity (Q: Dec. 2018 )
	=	101.502	-	78.528
	=	23.0

Osiris Therapeutics Total Liabilities Related Terms

Thank you for viewing the detailed overview of Osiris Therapeutics's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Osiris Therapeutics (Osiris Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Osiris Therapeutics Inc (NAS:OSIR) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

7015 Albert Einstein Drive, Columbia, MD, USA, 21046-1707

Website

http://www.osiris.com

Osiris Therapeutics is a biotechnology company involved in researching, developing, and marketing cellular regenerative medicine products. The company's therapeutic areas focus on innovation in regenerative medicine, including bioengineering, stem cell research, and viable tissue-based products. Osiris has accomplished commercial success with products in orthopedics, sports medicine, and wound care, such as Cartiform, Ovation, and Grafix.

Executives

Reinhart Charles A. Iii	director	C/O PACIRA PHARMACEUTICALS, INC., 5 SYLVAN WAY, SUITE 300, PARSIPPANY NJ 07054
Linda L Chang	officer: Chief Financial Officer	ONE PARK PLACE, STE 450, ANNAPOLIS MD 21401
Shauna L Vernal	officer: Chiel Legal Officer
Linda Palczuk	officer: President & CEO	7015 ALBERT EINSTEIN DRIVE, COLUMBIA MD 21046
David L White	director
Thomas J Knapp	director	4640 SW MACADAM AVE., SUITE 270, PORTLAND OR 97239
Jonathan Mark Hopper	officer: Chief Medical Officer	64 SIDNEY STREET, CAMBRIDGE MA 02139
Jacoby Philip R Jr	officer: Principal Accounting Officer
C Randal Mills	director, officer: President & CEO	18366 CALLE STELLINA, RANCHO SANTA FE CA 92091
Jay M Moyes	director
Stephen W Potter	officer: Senior Vice President	7015 ALBERT EINSTEIN DR, COLUMBIA MD 21046
Gregory Hurd Barnhill	director